VANGUARD GROUP INC 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:45 pm Sale | 2026-03-13 | 13G | ANIKA THERAPEUTICS INC ANIK | VANGUARD GROUP INC | 0 0.000% | -764,045 (Position Closed) | Filing |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | ANIKA THERAPEUTICS INC ANIK | VANGUARD GROUP INC | 764,045 5.220% | -219,723 (-22.33%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | ANIKA THERAPEUTICS INC ANIK | VANGUARD GROUP INC | 983,768 6.730% | 17,855 (+1.85%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | ANIKA THERAPEUTICS INC ANIK | VANGUARD GROUP INC | 965,913 6.690% | 31,631 (+3.39%) | Filing |